Tiefenbacher Pharmaceuticals successfully prepared the launch of the antihistamine Bilastine as Oral Dispersible Tablet (ODT) medicine in Germany
As the allergy season is in full swing, we at Tiefenbacher Group are thrilled to announce that we have successfully prepared the launch of our latest anti-allergy medicine, Bilastine Oral Dispersible Tablet (ODT) in Germany, which is now available in German pharmacies without prescription. We are particularly pleased to offer Bilastine (ODT) for the first time in 10mg strawberry flavoured tablets specifically for children aged 6-11 years.
Patients suffering from allergic symptoms such as hay fever, hives, urticaria, and other allergic reactions are hereby offered a more convenient and user-friendly way to control their allergy. The introduction of the oral dispersible tablet form is a response to the needs of patients who seek a more flexible and discreet way to manage their allergies, especially when on the go.
Bilastine Oral Dispersible Tablet (ODT) is designed to disintegrate quickly in the mouth without the need for water. This way patients who have difficulty swallowing pills or do not have immediate access to water can use it with ease.
The 10 mg tablets for children and the 20 mg tablets for adults have been developed in Tiefenbacher Group´s own laboratories and will be marketed by our partner, a well-known international pharmaceutical company. With the market entry of Bilastine Oral Dispersible Tablet we enable patients in Germany a better access to an important medicine which is currently available in pharmacies without a prescription needed.
Tiefenbacher Group is committed to continuously making high-quality medicines more affordable, more globally available, and better than before.
TIEFENBACHER PHARMACEUTICALS, a part of Tiefenbacher Group, develops and commercializes generic, value added, and innovative pharmaceuticals as well as medical devices and e-health-solutions worldwide. We provide over 180+ pharmaceutical products across various therapeutic categories in 10+ dosage forms. With our in-house product development and manufacturing, we can address specific therapeutic needs in unique formulations of prescription drugs (Rx) and over-the-counter (OTC) medicines for global markets.
For more information about our finished dosage forms (FDF) including highly potent drugs and e-healthcare solutions, please contact us at info@tiefenbacher.com or visit us on www.tiefenbacher-pharmaceuticals.com
About Tiefenbacher Group – Pioneering Healthcare since 1963
Tiefenbacher Group is a purpose-driven and 100% family-owned healthcare company. We are providing best-in-class solutions along the entire pharmaceutical value chain. From the initial idea to market access of high-quality medicines around the world: We distribute APIs and develop, produce, and register finished dosage forms (FDFs) including highly potent drugs as well as medical devices and e-health solutions. The purpose is to improve people’s lives by making pharmaceuticals more affordable, more available, and better than ever before.
For further information about TIEFENBACHER GROUP please contact us by email at info@tiefenbacher.com or visit us on: www.tiefenbachergroup.com
